Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer

Journal of Clinical Oncology

Volumn 18, Issue 23, 2000, Pages 3883-3893

  Morse, Michael A ^a   Nair, Smita ^a   Fernandez Casal, Monica ^a   Deng, Yuping ^a   St Peter, Michelle ^a   Williams, Rhonda ^a   Hobeika, Amy ^a   Mosca, Paul ^a   Clay, Tim ^a   Cumming, R Ian ^a   Fisher, Eva ^a   Clavien, Pierre ^a   Proia, Alan D ^a   Niedzwiecki, Donna ^a   Caron, Dania ^a   Lyerly, H Kim ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CELL INFILTRATION; CLINICAL ARTICLE; COLON CANCER; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN VIVO STUDY; LEUKOCYTE COUNT; LIVER METASTASIS; LUNG METASTASIS; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0034548854     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.23.3883     Document Type: Article

References (24)

1. Cellular and biological therapies of gastrointestinal tumors: Overview of clinical trials
2. Flt3 ligand stimulates/ costimulates the growth of myeloid stem/progenitor cells
3. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model
4. Flt 3 ligand administration inhibits tumor growth in murine melanoma and lymphoma
5. Flt3 ligand induces tumor regression and antitumor immune responses in vivo
6. Induction of dendritic cells (DC) by Flt3 ligand (FL) promotes the generation of tumor-specific immune responses in vivo
7. Flt3-ligand administration inhibits liver metastases: Role of NK cells
8. Dramatic increase in the numbers of functionally mature dendritic cells in flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
9. FLT3 ligand induces the generation of functionally active dendritic cells in mice
10. Generating a T cell tumor-specific immune response in vivo: Can flt3-ligand-generated dendritic cells tip the balance?
11. Expansion of functional NK cells in multiple tissue compartments of mice treated with flt3-ligand: Implications for anti-cancer and anti-viral therapy
12. Flt3 ligand antitumor activity in a murine breast cancer model: A comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action
13. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt 3 ligand as an adjuvant
14. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
15. Safety of Flt3 ligand in healthy volunteers
16. Flt3 ligand increases peripheral blood dendritic cells in healthy volunteers
17. Differential mobilization of distinct DC subsets in vivo by Flt3-ligand and G-CSF
18. In vivo mobilization of dendritic cell precursors in normal volunteers after FLT3-L administration
19. Mobilization of dendritic cells from patients with breast cancer using Flt3-ligand and G-CSF or GM-CSF
20. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor
21. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo
22. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival
23. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
24. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo